Skip to contentO
Opus Genetics, Inc.
O
IRDOpus Genetics, Inc. Q1 2016 · 10-Q
Revenue—
Net Income-$4.15M-$4.15MN/M vs Q1 2015 EPS Diluted-$0.20-$0.20N/M vs Q1 2015 Operating Income-$4,863,981N/M Operating Cash Flow-$3,549,617N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 6, 2016 · 36 d after period end